Variations in blood cancer survival across EuropeSeptember 28, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Blood cancer drugs set to be removed from CDFSeptember 9, 2015AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyALLMyelodysplastic Syndrome
Inhibitor could treat range of hematologic disordersJuly 29, 2015CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic SyndromeCML
Nivolumab produces ‘dramatic’ responses in HLJune 25, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Dose reductions make ponatinib safer for CP-CMLJune 18, 2015Leukemia, Myelodysplasia, TransplantationCML
Drug approved to treat CML, ALL in CanadaApril 7, 2015Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
Study reveals potential strategy for treating CMLApril 2, 2015Leukemia, Myelodysplasia, TransplantationCML
Israel approves ponatinib for CML, Ph+ ALLMarch 27, 2015Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
Skiing accident claims life of leukemia expertFebruary 26, 2015Leukemia, Myelodysplasia, TransplantationCML
Evolutionary findings may aid cancer drug developmentFebruary 20, 2015Leukemia, Myelodysplasia, TransplantationRelated IssuesCML
Approved TKI could treat drug-resistant CML, ALLFebruary 11, 2015Leukemia, Myelodysplasia, TransplantationALLCML
Though costly, blood cancer drugs appear cost-effectiveFebruary 8, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyCMLNon-Hodgkin Lymphoma